川崎氏病最严重的并发症是冠状血管和心脏受累。约14～30％的患者发生冠状动脉瘤,一些病例引起急性心肌梗死,2％的病例可能死亡。阿司匹林具抗炎和抗血小板的作用,是最广泛地用于治疗川崎氏病的药物。新近的研究表明30mg/kg/d的阿司匹林在降低冠状动脉受累率方面较抗生素没有明显的优势。因为研究证实在本病发热期,阿司匹林的吸收受到严重障碍,且上述剂量所 The most serious complication of Kawasaki disease is coronary blood vessels and heart involvement. About 14 to 30% of patients develop coronary aneurysms, some cases cause acute myocardial infarction, 2% of the cases may die. Aspirin has anti-inflammatory and anti-platelet effects and is the most widely used drug for treating Kawasaki disease. Recent studies have shown that aspirin at 30 mg / kg / d has no clear advantage over antibiotics in reducing the rate of coronary artery involvement. Because the study confirmed that the fever in this disease, the absorption of aspirin was severely obstructed, and the above dose